Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

  • Read more about Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

Dartsbio Pharmaceuticals Ltd.

By jpalfreyman on Wed, 10/09/2024 - 10:02
  • Read more about Dartsbio Pharmaceuticals Ltd.

StemCyte Inc.

By jpalfreyman on Wed, 10/09/2024 - 09:57
  • Read more about StemCyte Inc.

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

  • Read more about Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Summit Therapeutics

By jpalfreyman on Mon, 10/07/2024 - 16:48
  • Read more about Summit Therapeutics

OurSleepKit to Support CPAP Adherence

  • Read more about OurSleepKit to Support CPAP Adherence

PREPARE-M 2024 Undergoing Major Surgery: a Pilot Interventional

  • Read more about PREPARE-M 2024 Undergoing Major Surgery: a Pilot Interventional

Synbiotic Therapy for NP-PASC

  • Read more about Synbiotic Therapy for NP-PASC

Lymphocyte to Procalcitonin Ratio in Covid-19 Patients

  • Read more about Lymphocyte to Procalcitonin Ratio in Covid-19 Patients

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

  • Read more about Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Current page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA